Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Morphine and Dexmedetomidine in Abdominal Cancer Surgery
NCT03024957Phase 2Unknown
- Sponsor
- Assiut University
- Start
- Jan 2017
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexmedetomidine in Abdominal cancer, sponsored by Assiut University. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
Abdominal cancer
Beyond the preview
Go deeper on NCT03024957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03024957.